Chemokine expression in melanoma metastases associated with CD8+ T-cell recruitment - Wikidata - awgldk - TriplyDB

Chemokine expression in melanoma metastases associated with CD8+ T-cell recruitment

Chemokine expression in melanoma metastases associated with CD8+ T-cell recruitment

http://www.wikidata.org/entity/Q30415355

about

TCR-Engineered T Cells Meet New Challenges to Treat Solid Tumors: Choice of Antigen, T Cell Fitness, and Sensitization of Tumor Milieu Tumor-intrinsic oncogene pathways mediating immune avoidance Chimeric antigen receptor T-cell therapy for solid tumors Overcoming Barriers in Oncolytic Virotherapy with HDAC Inhibitors and Immune Checkpoint Blockade Novel technologies and emerging biomarkers for personalized cancer immunotherapy A Perspective of Immunotherapy for Breast Cancer: Lessons Learned and Forward Directions for All Cancers Lymphatic Vessels, Inflammation, and Immunity in Skin Cancer Cancer Dormancy: A Regulatory Role for Endogenous Immunity in Establishing and Maintaining the Tumor Dormant State The Next Hurdle in Cancer Immunotherapy: Overcoming the Non-T-Cell-Inflamed Tumor Microenvironment Reflections on the Histopathology of Tumor-Infiltrating Lymphocytes in Melanoma and the Host Immune Response Control of CD8 T-Cell Infiltration into Tumors by Vasculature and Microenvironment Acquired and intrinsic resistance in cancer immunotherapy Systems biology applied to vaccine and immunotherapy development Primer on tumor immunology and cancer immunotherapy Innate and adaptive immune cells in the tumor microenvironment The STING pathway and the T cell-inflamed tumor microenvironment Type I interferon response and innate immune sensing of cancer Cancer vaccines Cancer immunotherapy An immunologic portrait of cancer Recent advances in understanding antitumor immunity Molecular Pathways: Targeting the Stimulator of Interferon Genes (STING) in the Immunotherapy of Cancer Host type I IFN signals are required for antitumor CD8+ T cell responses through CD8{alpha}+ dendritic cells New perspectives on type I IFNs in cancer Trafficking of high avidity HER-2/neu-specific T cells into HER-2/neu-expressing tumors after depletion of effector/memory-like regulatory T cells Cancer immunotherapy via dendritic cells Control of immune cell entry through the tumour vasculature: a missing link in optimising melanoma immunotherapy?Human melanomas and ovarian cancers overexpressing mechanical barrier molecule genes lack immune signatures and have increased patient mortality risk.Topical treatment of melanoma metastases with imiquimod, plus administration of a cancer vaccine, promotes immune signatures in the metastases.Intratumoral interferon-gamma increases chemokine production but fails to increase T cell infiltration of human melanoma metastases.TLR2/6 agonists and interferon-gamma induce human melanoma cells to produce CXCL10 Chemokine receptor patterns in lymphocytes mirror metastatic spreading in melanoma.Oncogenic CARMA1 couples NF-κB and β-catenin signaling in diffuse large B-cell lymphomas.T cells in the human metastatic melanoma microenvironment express site-specific homing receptors and retention integrins Peptide vaccination in Montanide adjuvant induces and GM-CSF increases CXCR3 and cutaneous lymphocyte antigen expression by tumor antigen-specific CD8 T cells.A randomized phase II trial of multiepitope vaccination with melanoma peptides for cytotoxic T cells and helper T cells for patients with metastatic melanoma (E1602)Immunotype and immunohistologic characteristics of tumor-infiltrating immune cells are associated with clinical outcome in metastatic melanoma Molecular insights on the peripheral and intratumoral effects of systemic high-dose rIL-2 (aldesleukin) administration for the treatment of metastatic melanoma.Emerging concepts in biomarker discovery; the US-Japan Workshop on Immunological Molecular Markers in Oncology Cancer biomarker discovery: the entropic hallmark.

P2860

Q21131200-95F28F79-CF6D-41ED-9342-BF35AAFDA8E9 Q26747707-39DE4B04-0A02-4498-8377-10C8224F69A2 Q26750908-60942381-6EFB-4F48-8B00-9B25088A23CD Q26769977-CD87458A-7493-4A97-8F28-EB66F2FF89E5 Q26770780-7004C6DC-410D-4E17-945D-B9AAA398CA79 Q26777111-B2C1D06F-3D42-4B73-A8EE-B36AD4299B68 Q26778332-5FF3DF04-1F78-45CF-A703-3CDDCE9384BA Q26782573-CA533141-873A-4CF4-AEFD-84504EC3F83C Q26796305-0296FF38-CB11-414B-86A3-033D98FE7F61 Q26799073-EFAF329F-68D5-4A88-966A-227B51E75E2D Q26799117-C55B49B9-6596-4C94-A2C2-895DC1457B13 Q26827701-0DBD7C2E-53E7-48B0-8172-9DAA9360F62A Q26830374-6A093F21-62FD-410B-8557-ADEA0E40C071 Q27001126-323FA894-E401-4753-AF9C-09618DC53904 Q27008342-C7D85495-C0EF-483F-A880-15A27FCF0109 Q27008371-F82DF492-E7CC-45A0-9608-CCA66CBE7B91 Q27023235-724C26ED-9648-4A6E-9E16-DD141D6FA7CB Q27024438-C2AE92A0-6C5F-4743-8947-38CF1F902A93 Q27026870-A0296BFA-6A04-45AE-82F9-079CC592CB9D Q27028000-71DE2C10-2414-4A9F-8BB8-ED71E93FD045 Q28067217-DAC971EB-1985-48AA-84BF-BA30C73182DE Q28080773-A8A922E9-A922-46F4-9454-8537AA68F0EE Q28248489-6BCB08CF-7D93-4B39-AC33-7D413D21665C Q28256099-E376F252-AAB3-4D67-82A5-A13AF47E5B51 Q28732041-192128E0-6500-425A-88C7-84BBCCF08845 Q29615444-0F3C2DC7-0756-4BE0-B9C1-97C50A25C70F Q29994573-D7BEDD0D-6703-4258-99EC-44561CD98267 Q30274920-5A7814DD-5AEE-46F4-9101-277D0FE92F37 Q30276126-39DE95F3-D748-4A35-80D1-37CE85856A67 Q30276128-35D2D25D-4B67-4599-9463-CFF877E1620A Q30300383-6893CBE7-4B8A-4BEE-9F7B-CC95581BE35D Q30358552-BB449539-B6B2-4118-9173-5291AD1FA38E Q30375911-4C52AF5F-970B-46AF-B44B-3D4C98087AC0 Q30408331-5830196A-C1D4-43D1-8BDF-624B61A11AA6 Q30409722-5E9C0D8E-629F-4534-A703-FEE2EC649501 Q30411499-5B9338CD-3D44-4E1E-8D9F-799865314464 Q30422102-F97D07F3-C76A-4B7E-AA36-AF1250B1A3CB Q30423599-51B75058-1FDB-4623-ACEA-2308965CA394 Q30438965-BBAFCDB9-DE07-4ECC-A2FA-170B02ED2D29 Q30496149-5F5663E8-2713-4965-8A2E-6F7A17EA34EB

P2860

Chemokine expression in melanoma metastases associated with CD8+ T-cell recruitment

http://www.wikidata.org/entity/Q30415355

description

2009 nî lūn-bûn

@nan

2009 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի մարտին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Chemokine expression in melanoma metastases associated with CD8+ T-cell recruitment

@ast

Chemokine expression in melanoma metastases associated with CD8+ T-cell recruitment

@en

type

label

Chemokine expression in melanoma metastases associated with CD8+ T-cell recruitment

@ast

Chemokine expression in melanoma metastases associated with CD8+ T-cell recruitment

@en

prefLabel

Chemokine expression in melanoma metastases associated with CD8+ T-cell recruitment

@ast

Chemokine expression in melanoma metastases associated with CD8+ T-cell recruitment

@en

P1433

Q30415355-44AE1748-BBE9-488A-8929-9FBD3BB13A5E

P1476

Q30415355-70168901-7FE5-4148-B3CF-A6A3C843DB70

P2093

Q30415355-038ACABD-4073-4C85-95E6-A38223ADE3F6

Q30415355-1E4A37CF-6819-4AEB-BA61-BA47BBFBC1FB

Q30415355-4091D821-F378-4FBF-92BF-CFA02D8936C1

Q30415355-42D04117-0900-474F-8E5E-DD35E94A00D2

Q30415355-492FE2DB-264D-4B92-BE13-2254DC1C0900

Q30415355-E06137F2-8F83-4C57-BBAF-FA9A9FF52E8B

Q30415355-F20829C5-68B0-4C5D-A7DE-7113DF04A7AF

P2860

Q30415355-332F1A56-8D40-4A98-BEE2-D5CCFA1A77A9

Q30415355-36E8185E-29B5-42A0-AF26-35FBF99AE478

Q30415355-4D306E40-6ABB-4C7B-B507-240CFD9D99AE

Q30415355-4E18C892-ADC0-410F-8337-AA8E35E4EEF8

Q30415355-5202BDB8-6F05-460A-AD86-8126F102C81B

Q30415355-5B73999A-FABC-4EBE-8935-4A90FB3A8268

Q30415355-894B5FA2-49C1-484D-8CB9-9699C05C3422

Q30415355-8A9E8A88-C98B-4591-BB73-B5FDEE4D922B

Q30415355-961A2B1C-011B-4206-A561-5A0ACF38AD73

Q30415355-A021BB51-4224-4E27-B641-DF1A937D7F9C

P304

Q30415355-41D4C857-6D2B-4A77-BA7D-CCC296360B48

P31

Q30415355-942B7FFD-CBA3-46FE-A655-DF29D08AEAB2

P356

Q30415355-7EC89D40-01F9-466C-9A33-FE5E80C5CFBA

P407

Q30415355-844AF699-6F63-412A-AE0D-7B81976685E9

P433

Q30415355-BD617069-419E-4370-8080-D553F952290E

P478

Q30415355-06BD5E6D-2001-4A43-91CD-4CCCC1A098F8

P50

Q30415355-9D6BEA62-3EE1-4060-9336-A24CB04113BE

P577

Q30415355-6177A5E5-BF90-4811-8503-BAA2472F271E

P698

Q30415355-328B02EE-5A2E-4964-A730-FC6EC76D37DD

P932

Q30415355-9095CB63-6C8F-41DA-A8FB-35D9B72460FD

P356

0008-5472.CAN-08-2281

P1433

Cancer Research

P1476

Chemokine expression in melanoma metastases associated with CD8+ T-cell recruitment

@en

P2093

Amy C Peterson

http://www.w3.org/2001/XMLSchema#string

Helena Harlin

http://www.w3.org/2001/XMLSchema#string

Maria Tretiakova

http://www.w3.org/2001/XMLSchema#string

Mark McKee

http://www.w3.org/2001/XMLSchema#string

Thomas F Gajewski

http://www.w3.org/2001/XMLSchema#string

Yuanyuan Zha

http://www.w3.org/2001/XMLSchema#string

Yuru Meng

http://www.w3.org/2001/XMLSchema#string

P2860

Mutations of the BRAF gene in human cancer

Chemokines: a new classification system and their role in immunity

CXC chemokine receptor 3 expression by activated CD8+ T cells is associated with survival in melanoma patients with stage III disease.

Evidence for differential expression of Notch receptors and their ligands in melanocytic nevi and cutaneous malignant melanoma.

The role of LIGHT in T cell-mediated immunity.

CXCR3 chemokine receptor immunoreactivity in primary cutaneous malignant melanoma: correlation with clinicopathological prognostic factors

Immune resistance orchestrated by the tumor microenvironment.

Targeting the primary tumor to generate CTL for the effective eradication of spontaneous metastases.

Enhancement of cellular immunity in melanoma patients immunized with a peptide from MART-1/Melan A

Stat3 activity in melanoma cells affects migration of immune effector cells and nitric oxide-mediated antitumor effects.

P304

3077-3085

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/0008-5472.CAN-08-2281

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

69

http://www.w3.org/2001/XMLSchema#string

P50

Craig Slingluff

P577

2009-03-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19293190

http://www.w3.org/2001/XMLSchema#string

P932

3886718

http://www.w3.org/2001/XMLSchema#string